Satish Garg MD

Dr. Garg joined the faculty of Barbara Davis Center in 1992 to become the founder and director of BDC adult clinic. His research interests include the early detection and treatment of renal and retinal complications of type 1 diabetes, and the development of new diagnostic and therapeutic tools related to clinical diabetes management that include new insulin analogs and glucose sensors, artificial pancreas studies, evaluating accuracy of meters at high altitude, alternate ways to deliver insulin, adjunctive therapies for T1D etc. He has been part of several seminal multicenter studies that have brought technological breakthroughs to diabetes care including the recently FDA approved Medtronic MiniMed 670G hybrid closed-loop system. Dr. Garg is the Editor in chief of Diabetes Technology and Therapeutics Journal and Chair of the planning committee for Clinical Therapeutics and New Technology area for 2007 and 2008 Annual American Diabetes Associations meetings. He is the director of ATDC Keystone Diabetes conference since 2005. He is an international lecturer and speaker, and has published many chapters in the books, on the editorial boards for many of the diabetes journals globally and has published more than 250 original manuscripts in peer-review journals.